News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
863,810 Results
Type
Article (87570)
Company Profile (827)
Press Release (775393)
Multimedia
Podcasts (179)
Webinars (28)
Section
Business (233114)
Career Advice (4140)
Deals (39817)
Drug Delivery (141)
Drug Development (91296)
Employer Resources (203)
FDA (18303)
Job Trends (17407)
News (397525)
Policy (39933)
Tag
Academia (3005)
Academic (2)
Accelerated approval (19)
Adcomms (35)
Allergies (133)
Alliances (56980)
ALS (148)
Alzheimer's disease (1695)
Antibody-drug conjugate (ADC) (272)
Approvals (18345)
Artificial intelligence (526)
Autoimmune disease (111)
Automation (30)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (168)
Biotechnology (485)
Bladder cancer (140)
Brain cancer (53)
Breast cancer (534)
Cancer (4252)
Cardiovascular disease (380)
Career advice (3562)
Career pathing (38)
CAR-T (259)
CDC (57)
Cell therapy (719)
Cervical cancer (33)
Clinical research (75985)
Collaboration (1468)
Company closure (4)
Compensation (986)
Complete response letters (64)
COVID-19 (2966)
CRISPR (88)
C-suite (639)
Cystic fibrosis (143)
Data (5153)
Decentralized trials (2)
Denatured (65)
Depression (118)
Diabetes (472)
Diagnostics (7121)
Digital health (39)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (251)
Drug pricing (196)
Drug shortages (36)
Duchenne muscular dystrophy (210)
Earnings (99550)
Editorial (56)
Employer branding (25)
Employer resources (172)
Events (133744)
Executive appointments (1000)
FDA (20921)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (19)
Funding (1314)
Gene editing (186)
Generative AI (52)
Gene therapy (577)
GLP-1 (1050)
Government (5398)
Grass and pollen (8)
Guidances (375)
Healthcare (20940)
HIV (49)
Huntington's disease (41)
IgA nephropathy (75)
Immunology and inflammation (265)
Immuno-oncology (22)
Indications (61)
Infectious disease (3221)
Inflammatory bowel disease (193)
Inflation Reduction Act (16)
Influenza (104)
Intellectual property (202)
Interviews (816)
IPO (17933)
IRA (59)
Job creations (5197)
Job search strategy (2866)
Kidney cancer (17)
Labor market (82)
Layoffs (644)
Leadership (37)
Legal (10152)
Liver cancer (93)
Longevity (13)
Lung cancer (602)
Lymphoma (291)
Machine learning (33)
Management (66)
Manufacturing (679)
MASH (155)
Medical device (14919)
Medtech (14948)
Mergers & acquisitions (22806)
Metabolic disorders (1224)
Multiple sclerosis (143)
NASH (23)
Neurodegenerative disease (240)
Neuropsychiatric disorders (65)
Neuroscience (2788)
NextGen: Class of 2025 (7707)
Non-profit (5098)
Now hiring (60)
Obesity (587)
Opinion (317)
Ovarian cancer (148)
Pain (173)
Pancreatic cancer (183)
Parkinson's disease (248)
Partnered (32)
Patents (436)
Patient recruitment (347)
Peanut (57)
People (66395)
Pharmaceutical (145)
Pharmacy benefit managers (29)
Phase I (23438)
Phase II (32974)
Phase III (24865)
Pipeline (3109)
Policy (307)
Postmarket research (3554)
Preclinical (10595)
Press Release (72)
Prostate cancer (208)
Psychedelics (52)
Radiopharmaceuticals (283)
Rare diseases (720)
Real estate (7424)
Recruiting (79)
Regulatory (28182)
Reports (65)
Research institute (2700)
Resumes & cover letters (651)
Rett syndrome (18)
RNA editing (15)
RSV (78)
Schizophrenia (140)
Series A (215)
Series B (160)
Service/supplier (30)
Sickle cell disease (85)
Special edition (26)
Spinal muscular atrophy (170)
Sponsored (42)
Startups (4320)
State (2)
Stomach cancer (17)
Supply chain (103)
Tariffs (96)
The Weekly (112)
Vaccines (1071)
Venture capital (69)
Weight loss (414)
Women's health (64)
Worklife (21)
Date
Today (164)
Last 7 days (1205)
Last 30 days (3709)
Last 365 days (33651)
2025 (29346)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1285)
Alabama (81)
Alaska (7)
Arizona (312)
Arkansas (14)
Asia (51110)
Australia (8985)
California (10161)
Canada (2975)
China (968)
Colorado (424)
Connecticut (451)
Delaware (290)
Europe (117513)
Florida (1484)
Georgia (329)
Hawaii (3)
Idaho (68)
Illinois (835)
India (56)
Indiana (494)
Iowa (20)
Japan (341)
Kansas (128)
Kentucky (39)
Louisiana (27)
Maine (80)
Maryland (1343)
Massachusetts (7570)
Michigan (323)
Minnesota (595)
Mississippi (4)
Missouri (127)
Montana (33)
Nebraska (26)
Nevada (110)
New Hampshire (81)
New Jersey (2797)
New Mexico (32)
New York (2708)
North Carolina (1465)
North Dakota (10)
Northern California (4717)
Ohio (312)
Oklahoma (22)
Oregon (51)
Pennsylvania (2085)
Puerto Rico (20)
Rhode Island (46)
South America (1655)
South Carolina (52)
South Dakota (1)
Southern California (3875)
Tennessee (155)
Texas (1574)
United States (37108)
Utah (304)
Virginia (258)
Washington D.C. (85)
Washington State (857)
West Virginia (4)
Wisconsin (105)
Wyoming (2)
There are 863,810 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Cardiovascular disease
Amgen, Merck, Novo, More Take Cardiovascular Benefits to New Heights at AHA 2025
Data presented at this year’s American Heart Association Scientific Sessions in New Orleans underline rapid advancements in the cardiovascular field.
November 11, 2025
·
5 min read
·
Tristan Manalac
Depression
Neurocrine’s Depression Drug Delivers ‘Surprise’ Phase II Miss
The mid-stage failure was unexpected to analysts at BMO Capital Markets, who viewed ‘770 as mostly derisked given its similar mechanism of action to Johnson & Johnson’s Spravato.
November 11, 2025
·
2 min read
·
Tristan Manalac
Cancer
Cogent Hits ‘Unprecedented’ Efficacy in Rare Stomach Cancer, Clearing Path to FDA
Cogent Biosciences expects to file a new drug application for bezuclastinib in gastrointestinal stromal tumors early next year after what Leerink said was “the first positive trial in this disease in over a decade.”
November 11, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Zomedica Announces “Friday at Four” Webinar on November 21st Providing Strategic Overview & Third Quarter 2025 Business Review
November 11, 2025
·
6 min read
Press Releases
Applied StemCell Demonstrates Efficient Knock-In of a 50 kb DNA Construct into Human iPSCs Using TARGATT™ Technology
November 11, 2025
·
3 min read
Press Releases
Vor Bio Announces Pricing of Public Offering of $100 Million of Common Stock
November 11, 2025
·
4 min read
Press Releases
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - November 10, 2025
November 11, 2025
·
2 min read
Press Releases
Samsung Epis Holdings Announces Establishment of Epis NexLab, a New Subsidiary to Advance Next-Generation Biotechnology Platforms
November 11, 2025
·
1 min read
Press Releases
Ariceum Therapeutics Doses First Patient in SANTANA-225 Phase 1/2 Clinical Trial of 225Ac-SSO110 in Patients with Extensive-Stage Small Cell Lung Cancer or Merkel Cell Carcinoma
November 11, 2025
·
3 min read
Press Releases
AlzeCure Publishes its Interim Report for January - September 2025
November 11, 2025
·
6 min read
1 of 86,381
Next
